Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease

Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy

NCT03629782 ·Status: COMPLETED

Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics

NCT00252291 ·Status: COMPLETED ·Phase: PHASE3

A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

NCT00130351 ·Status: COMPLETED ·Phase: PHASE3

Study in Patients With Asthma

NCT00215358 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Asthmatic Patients

NCT00910793 ·Status: COMPLETED ·Phase: PHASE4

Determining the Optimal Adenosine Provocation Test

NCT01610921 ·Status: COMPLETED ·Phase: NA

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00252863 ·Status: COMPLETED ·Phase: PHASE3

Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting

NCT00235911 ·Status: COMPLETED ·Phase: PHASE3

A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma

NCT02479412 ·Status: COMPLETED ·Phase: PHASE2

Characteristics of Pts Initiating Spiriva Respimat in Asthma

NCT03692676 ·Status: COMPLETED

Study to Investigate the Effect of Inhaled Tiotropium Bromide on Neurokinin-A Induced Bronchoconstriction in Patients With Mild-to-moderate Asthma

NCT00557700 ·Status: COMPLETED ·Phase: PHASE2

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

NCT00479739 ·Status: COMPLETED ·Phase: PHASE4

To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma

NCT02195284 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Pharmacokinetics and Pharmacodynamics of AZD4604 Given Via the Turbuhaler® Device in Adults With Mild Asthma.

NCT06732882 ·Status: COMPLETED ·Phase: PHASE1

Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient

NCT01085474 ·Status: COMPLETED

Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic Obstruct

NCT01426893 ·Status: COMPLETED

Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice

NCT00782314 ·Status: COMPLETED

Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

NCT00189787 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma

NCT00411567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL

NCT00801853 ·Status: COMPLETED ·Phase: PHASE2

Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants

NCT05791565 ·Status: COMPLETED ·Phase: PHASE1

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

NCT00096616 ·Status: COMPLETED ·Phase: PHASE2

Prospective evAluatIon foR Inhalation Devices Study

NCT01800994 ·Status: COMPLETED

Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129)

NCT00163332 ·Status: COMPLETED ·Phase: PHASE3

A Study of Inhaler Use in the Community

NCT02552472 ·Status: COMPLETED